Fed. Circ. Written Description Scrutiny Has Lessons For Attys

Two recent Federal Circuit decisions finding drug patents invalid for not adequately describing the claimed invention highlight how important it is to review patent applications during research and development to ensure...

Already a subscriber? Click here to view full article